| Financial Year |
March 31 2023 |
| Monetary Funds |
55,595,123.10 |
| Held-for-trading Financial Assets |
208,526,089.42 |
| Notes Receivable |
96,588.00 |
| Accounts Receivable |
6,461,742.19 |
| Advances to Suppliers |
380,908.30 |
| Other Receivables |
240,066.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
27,685,320.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
298,985,837.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
63,211,926.54 |
| Fixed Assetes |
78,844,896.74 |
| Under-construction Projects |
5,339,000.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
35,671,394.68 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
6,675,958.54 |
| Other Non-Current Assets |
1,475,669.60 |
| Sub-Total of Non-Current Assets |
191,404,805.42 |
| Total Assets |
490,390,642.70 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
10,187,730.80 |
| Accounts Received In Advance |
537,858.71 |
| Employee Compensation Payable |
1,577,005.08 |
| Taxes Payable |
2,023,876.57 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
32,711,627.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
18,943,748.81 |
| Other Current Liabilities |
24,476.36 |
| Sub-Total of Current Liabilities |
67,344,481.36 |
| Long-term Loans |
23,772,140.25 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
256,807.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
24,441,447.61 |
| Total Liabilities |
91,785,928.97 |
| Paid-In Capital(Or Share Stock) |
219,700,000.00 |
| Capital Surplus |
117,799,200.00 |
| Surplus Reserve |
32,668,913.13 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
28,436,600.60 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
398,604,713.73 |
| Owner's Equity（Stockholder's Equity） |
398,604,713.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
490,390,642.70 |
